Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis-Reference-Cited by-全球学者库

Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis

Published:2021-01-01 Issue:1 Volume:28 Page:1007-1019
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Fu Wenhai¹,He Wenjun²,Li Yuexin¹,Chen Yangxiao¹,Liang Jingyi²,Lei Hui²,Fu Lin¹,Chen Yanghang²,Ren Ni²,Jiang Qian²,Shen Yi²,Ma Ran²,Wang Tao²,Wang Xinni²,Zhang Nuofu²,Xiao Dakai²,Liu Chunli²

Affiliation:

1. Department of Medicine, First Clinical School, Guangzhou Medical University, Guangzhou, China

2. Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China

Funder

the State Key Laboratory of Respiratory Disease

the National Key Research and Development Program of China

the Construction Plan of High-level University Clinical Research Promotion Plan of Guangzhou Medical University

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2021.1927243

Reference85 articles.

1. Sildenafil-Bosentan Drug-Drug Interaction: A Word of Caution Regarding the Most Common Combination Therapy in Children with Advanced Pulmonary Arterial Hypertension